MJO Bank Of Montreal Microsectors Cannabis 2X Leveraged Etns
- 81.164
- 0.0000.00%
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 6.43% on an annualized basis producing an average annual return of 16.92%. Currently, Thermo Fisher Scientific
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
AbbVie Wins EU Backing for Skyrizi in Bowel Disorder
Qualigen Therapeutics Receives Nasdaq Notice of Delisting Determination
TD Cowen Maintains Buy on Agilent Technologies, Lowers Price Target to $153
TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and lowers the price target from $163 to $153.
Tech, Blue Chip Stocks Drop; Small Caps, Real Estate Rebound As Yields Ease; Solar Industry Shines: What's Driving Markets Thursday?
Wall Street experienced another decline on Thursday, with major large-cap indices affected by a downturn in the tech and communication services sectors. Investors shifted their focus to market areas t
Cracking The Code: Understanding Analyst Reviews For Agilent Technologies
Analysts' ratings for Agilent Technologies (NYSE:A) over the last quarter vary from bullish to bearish, as provided by 9 analysts.Summarizing their recent assessments, the table below illustrates the
Ecopetrol Cut to Sell Equivalent at BofA as Macro Concerns Muddy the Waters
Predictive Oncology, Augmedix, Cue Health Among Healthcare Movers
Baird Maintains Outperform on Agilent Technologies, Lowers Price Target to $136
Baird analyst Catherine Schulte maintains Agilent Technologies (NYSE:A) with a Outperform and lowers the price target from $147 to $136.
Agilent Technologies Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 7.09% Baird $147 → $136 Maintains Outperform 04/10/2024 6.3% Barclays $125 → $135 Maintains Und
Wall Street On Backfoot As Traders Sweat Over Key Inflation Data: Economist Warns Stock Rally May Stumble If Bond Yield Crosses This Level
U.S. stocks are likely to remain weak on Thursday, major index futures indicated, as lower bond yields stayed elevated and mixed earnings dampened sentiment. On traders' radar are key inflation data f
Insiders Buying Hilton Worldwide And 2 Other Stocks
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the st
Agilent Shares Are Trading Lower Following Mixed Q2 Earnings and Weak Guidance.
Agilent Shares Are Trading Lower Following Mixed Q2 Earnings and Weak Guidance.
Agilent Down 14% Following Revised 2024 Guidance
Agilent Plans To Repurchase $0.75B Of Its Common Stock By The End Of The Fiscal Year, And The Board Recently Authorized A New $2B Share Repurchase Program
Agilent Plans To Repurchase $0.75B Of Its Common Stock By The End Of The Fiscal Year, And The Board Recently Authorized A New $2B Share Repurchase Program
Agilent Shares Are Trading Lower Following Mixed Q2 Earnings.
Agilent Shares Are Trading Lower Following Mixed Q2 Earnings.
AbbVie Shares Fell for Seven Straight Days
6-K: Report of foreign private issuer (related to financial reporting)
Wall Street Set To Open Weaker As Bond Yields Rise, Meme Rally Cools: Analyst Says Stick With What's Working Amid Volatility
U.S. stocks are poised to open lower on Wednesday following the boost from the tech rally in the previous session. The spotlight will likely be on bond yields, which have climbed in recent sessions on